Plain-English translation of NCT06046131 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is trying to understand why prostate cancer behaves differently in different men—why some cases grow very slowly and others progress quickly with serious complications. Researchers will follow 3,000 newly diagnosed prostate cancer patients at two hospitals (one in Guadeloupe and one in France) over time, collecting information about their health, lifestyle, family history, work environment, and biological samples like blood and saliva. By studying these factors across different populations, the research team hopes to learn which combinations of genes, environment, and life circumstances influence how each person's cancer will evolve and respond to treatment.
Right now, doctors cannot reliably predict which prostate cancer patients will have slow-growing disease and which will have aggressive, fast-spreading cancer. This uncertainty makes treatment planning difficult and means some patients may be over- or under-treated. This study exists to identify the medical, genetic, and environmental factors that determine how each man's cancer will progress, so that doctors can eventually predict outcomes and personalize treatment better.
You likely qualify if…
You likely don't qualify if…
You will visit one of the two study hospitals (in Guadeloupe or Brittany) at the time of your cancer diagnosis and at regular times afterward. At each visit, researchers will ask you detailed questions about your life (work history, where you've lived, lifestyle habits), take measurements like blood pressure and weight, and collect samples of blood, urine, and saliva. Your doctors will also share information about your cancer and how you're responding to treatment. This monitoring will continue over several years, allowing researchers to track how your cancer changes over time and identify patterns that help explain why cancers progress differently in different men.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
France
Guadeloupe